TREATMENT OUTCOME AND DETERMINANTS AMONG PATIENTS WITH VISCERAL LEISHMANIASIS IN ARBA MINCH GENERAL HOSPITAL LEISHMANIASIS RESEARCH AND TREATMENT CENTER, GAMO GOFA ZONE, SNNPR, ETHIOPIA
Journal Title: INNOVATIVE JOURNAL OF MEDICAL AND HEALTH SCIENCE - Year 2018, Vol 8, Issue 8
Abstract
- Introduction: Visceral Leishmania represents a challenging diagnosis and treatment because the clinical picture of Visceral Leishmaniasis, so that the treatment outcome is compromised with many factors, thus study try to asses real picture of treatment outcome with determinants. Objective: To assess treatment outcome and determinant factors among patient with visceral Leishmaniasis in Arba Minch General Hospital Leishmania Research and Treatment Center. Methods: Institution-based, Cross-sectional, retrospective study was conducted among Leishmaniasis patients in Arba Minch general hospital. Patient charts that have been treated from January 2011-December 2015 were reviewed. A total of 348 charts were selected by Simple Random Sampling technique and included in the study. The data were entered and cleaned using Epi-info version 7.0 and analysis was carried out using SPSS-20 statistical packages. Multi-variate logistic regression analysis was carried out to identify the independent predictors of treatment outcome. Result: A total of 348 patient's charts were included in the study. The prevalence of poor outcome was found to be 8.6%. The presence of bleeding/Epsitaxis[AOR=5;95% CI:1.3,19.3], tuberculosis[AOR=3.7;95%CI:1.83,6.3], septic syndrome[AOR=4.3;95% CI: 6.1,32], and adverse drug side effect[AOR=4.5;95%CI:2.73,13.6] were the independent predictors of treatment outcome. Conclusion and recommendation: The prevalence of poor treatment outcome among patients with VL in the study area is high. Concomitant infection; bleeding/Epsitaxis, tuberculosis, septic syndrome and adverse side effect were independently associated with poor treatment outcome. The clinical management of VL in co-infected patients is a major challenge that requires new treatment approaches to improve its outcome.
Authors and Affiliations
AMSALU Mr. ALEMU TAMISO*
Keywords
Related Articles
- EP ID EP443446
- DOI 10.15520/ijmhs.v8i8.2279
- Views 75
- Downloads 0
Study of cholesterol activity in pleural effusion
Background: Pleural effusions are collections of fluid in pleural cavities and areactually manifestations of diverse diseases both infective and non infective and alsocardio-pulmonary in origin or extra-pulmonary. Based...
COMPLEX-IV DEFICIENCY MANIFESTING ASCEREBRAL-DOMINANT MITOCHONDRIAL MULTIORGANDISORDER SYNDROME (MIMODS)
Recently, Arilla et al. presented a 36 years old Caucasian female, who was misdiagnosed as a pure psychiatric disorder (somatisation and conversion disorder, maniac episode, affective psychosis, “special†personality)...
Assessment of Knowledge, Attitude and Practice of Health Care Providers towards the Prevention and Control of Multi Drug Resistant Tuberculosis at Nekemte Referral Hospital, Western Ethiopia
Background: Tuberculosis (TB) has existed for millennia and remains a major global health problem. Although it may be assumed that in general health care workers (HCWs) know about MDR-TB and its implications, several stu...
Saphenofemoral Arteriovenous Fistula as Hemodialysis access: PPUKM Early Experience
The biggest and difficult challenge in hemodialysis access is to maintain it over the time in the expanding number of patients with end-stage renal failure (1). There is little consensus discussed about the option availa...
CASE REPORT: ANESTHETIC MANAGEMENT OF A PATIENT PRESENTING WITH NEUROFIBROMATOSIS TYPE 2
The paper presents the rare case of neurofibromatosis type 2 scheduled for hysterectomy. The 39 year old female patient admitted in obgy department with chief complaint of dysmenorrhea .Hist...